SENNOSIDES AND DOCUSATE SODIUM
- Product NDC
- 49483-097
- 11-digit product format
- 494830097
- Labeler code
- 49483
- Product ID
- 49483-097_2d9c974f-7555-3b50-e063-6294a90a406a
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- SENNOSIDES AND DOCUSATE SODIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- TIME CAP LABORATORIES, INC
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2010-01-01
- Substance
- DOCUSATE SODIUM; SENNOSIDES
- Active strength
- 50; 8.6 mg/1; mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49483-097-00 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49483-097-01 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49483-097-00 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49483-097-01 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49483-097-00 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49483-097-01 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 49483-097-01 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 49483-097-00 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 49483-097-01 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 49483-097-00 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SENNOSIDES AND DOCUSATE SODIUM
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SENNOSIDES | 8.6 mg/1 |
| DOCUSATE SODIUM | 50 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3FYP5M0IJX | Internal UNII lookup |
| F05Q2T2JA0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 998740 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0ad617e0-10a6-44fa-be62-4f3cc725fb01 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49483-097-00 | SENNOSIDES AND DOCUSATE SODIUM | 100000 in 1 CARTON | TABLET, FILM COATED | 100000 | 3 | |
| 49483-097-01 | SENNOSIDES AND DOCUSATE SODIUM | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 3 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SENOKOT | STANDARDIZED SENNA | A-S Medication Solutions | 0c6e6bdd-9f49-4550-b60a-8f58b7c0f090 | 2026-09-09 | Warnings | M007 |
| Bisacodyl | BISACODYL | KROGER COMPANY | a13a8eec-3652-8c57-e053-2995a90aaebf | 2026-09-09 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | TARGET Corporation | 4180a35b-cc50-46ae-a100-99bb218c10ff | 2026-09-09 | Warnings | M007 |
| fiber laxative | PSYLLIUM HUSK | Raritan Pharmaceuticals Inc | 22e927bd-5734-424e-8870-1aaa18f1265e | 2026-09-08 | Warnings | M007 |
| DRx Choice Fiber Therapy | METHYLCELLULOSE | RARITAN PHARMACEUTICALS INC | 5e5749f7-074e-4bbc-9f33-5090e603fdb4 | 2026-09-08 | Warnings | M007 |
| Bisacodyl Stimulant Laxative | BISACODYL | Raritan Pharmaceuticals Inc | b99c1a6d-3034-4822-8540-210179c06857 | 2026-09-08 | Warnings | M007 |
| Daily Fiber Sugar Free | PSYLLIUM HUSK | Raritan Pharmaceuticals Inc | 9c4c41d8-a2d5-4168-9e97-9f9d47fc5e63 | 2026-09-08 | Warnings | M007 |
| DRx Choice Fiber Therapy | METHYLCELLULOSE | RARITAN PHARMACEUTICALS INC | 56c7f197-f01a-4611-a761-cda18da6eed0 | 2026-09-08 | Warnings | M007 |
| Sennosides 8.6 mg | SENNOSIDES | Morepen Bio Inc | 562c9f11-0ba1-011d-e063-6394a90a604a | 2026-09-05 | Warnings | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Target Corporation | 87f98e6c-a3a1-4ca5-bd56-977e38f48914 | 2026-09-04 | Warnings, Adverse reactions | M007 |
| Kroger Stool Softener Fruit Punch | DOCUSATE SODIUM | KROGER COMPANY | b86f8f3d-594e-466c-854a-b8bff9f7a0b8 | 2026-09-02 | Warnings | M007 |
| Oil | MINERAL OIL | Atlantic Biologicals Corp. | 5a82197b-281d-76c0-e063-6294a90a5746 | 2026-09-02 | Warnings, Adverse reactions | M007 |
| Kroger Senna Laxative Regular Strength | SENNOSIDES | KROGER COMPANY | dbb040bb-21f9-43e8-9705-689aeee4d04c | 2026-09-01 | Warnings | M007 |
| OneLAX SENNA | SENNA | Akron Pharma Inc. | 27fa8f54-ed84-4afd-8da3-8754da48643b | 2026-09-01 | Warnings | M007 |
| OneLAX Saline Laxative | MAGNESIUM CITRATE | AKRON PHARMA INC | 44c87bbc-2507-4b87-a74b-02f4acb30cf4 | 2026-09-01 | Warnings | M007 |
| OneLAX Saline Laxative | MAGNESIUM CITRATE | AKRON PHARMA INC | e6de00e6-dd81-4aab-af23-04fab261c6ff | 2026-09-01 | Warnings | M007 |
| EZ2Go Magnesium Citrate Saline Laxative Lemon Flavor | MAGNESIUM CITRATE | Valley Medical Products LLC | 5a71e88c-d8cc-a8bb-e063-6294a90af4f7 | 2026-09-01 | Warnings | M007 |
| Fiber Caplets | CALCIUM POLYCARBOPHIL | THE KROGER CO. | d6856f59-ccc3-40fc-9bf1-7a5394ed12da | 2026-09-01 | Warnings | M007 |
| Mineral Oil | MINERAL OIL | Your Military Exchanges | 6025dce6-02e8-418c-a248-0b5c33ff6067 | 2026-08-28 | Warnings, Adverse reactions | M007 |
| Magnesium Citrate | MAGNESIUM CITRATE | Chain Drug Marketing Association | 583b64e7-e48d-6ba6-e063-6294a90ad4d7 | 2026-08-28 | Warnings, Adverse reactions | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 998740 | sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet | PSN | 0ad617e0-10a6-44fa-be62-4f3cc725fb01 | 3 |
| 998740 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SCD | 0ad617e0-10a6-44fa-be62-4f3cc725fb01 | 3 |
| 998740 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SY | 0ad617e0-10a6-44fa-be62-4f3cc725fb01 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 49483-097-00 | 49483009700 | 100000 TABLET, FILM COATED in 1 CARTON (49483-097-00) | 2010-01-01 | 0000-00-00 | No | No | Current |
| 49483-097-01 | 49483009701 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (49483-097-01) | 2010-01-01 | 0000-00-00 | No | No | Current |